Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.
about
Stroke and the "stroke belt" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variationVariation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regionsRelationship between stroke and mortality in dialysis patients.Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.The association between geographic proximity to a dialysis facility and use of dialysis cathetersRegional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis.Association between higher rates of cardioprotective drug use and survival in patients on dialysisGeographic and facility variation in initial use of non-tunneled catheters for incident maintenance hemodialysis patients.Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.Association of race with cumulative exposure to statins in dialysis.Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients.Relationship between calcium channel blocker class and mortality in dialysis.Atrial fibrillation and risk of stroke in dialysis patients.Impact of race on cumulative exposure to antihypertensive medications in dialysisRace, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients.Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
P2860
Q28391692-885BE7C4-5C05-4274-8276-15C0F96DDB1DQ34292926-99E1759C-6155-44E5-B16D-5435E56A7C3AQ34828501-20D3F76C-6DA7-4B86-8EE8-2B320C00FE55Q35039319-AE19D298-8EDE-488C-A568-466C63C33739Q35103992-88DC669A-DA54-4C94-80B8-3E0BC645A1C4Q35699863-FCA9BCF2-9496-45A9-AB2E-43BD2E417788Q35812557-FE6FAAE0-213E-4D19-8316-60BACC78E06CQ35937884-C9D20C6A-9FB1-43A8-ACCD-F759239135B9Q35969769-458723AF-8EB6-4DBA-ADFD-103A714AF5A0Q36160297-71008EB4-D944-4B88-9718-C4C2CC3FB405Q36239524-656B21E5-B7AD-4527-821C-31313F360C11Q36331383-BABF72CF-E89A-4C34-AE84-EE2C1D91B1F5Q36469666-A06C8C0C-5196-40F8-A79C-3DC323C7A847Q36605061-1184A7C5-1CB5-4E5E-9781-5503062F1E8CQ36764881-632BDA8F-EC5C-4C18-84EF-E0F9464691BBQ37682243-3A0FE84A-DCB2-4AE8-A971-325E2F6A49FAQ45784975-665F73F4-3CF0-46C8-AC22-08762579A472
P2860
Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Geographic variation in cardio ...... on usage in dialysis patients.
@ast
Geographic variation in cardio ...... on usage in dialysis patients.
@en
type
label
Geographic variation in cardio ...... on usage in dialysis patients.
@ast
Geographic variation in cardio ...... on usage in dialysis patients.
@en
prefLabel
Geographic variation in cardio ...... on usage in dialysis patients.
@ast
Geographic variation in cardio ...... on usage in dialysis patients.
@en
P2093
P2860
P1476
Geographic variation in cardio ...... on usage in dialysis patients.
@en
P2093
Edward F Ellerbeck
James B Wetmore
Jonathan D Mahnken
Purna Mukhopadhyay
Qingjiang Hou
Sally K Rigler
Theresa I Shireman
P2860
P356
10.1053/J.AJKD.2011.02.387
P577
2011-05-31T00:00:00Z